These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17714926)

  • 1. Response to: Scottish Intercollegiate Guidelines Network (SIGN) 84 -- National Clinical Guideline for the Management of Breast Cancer in Women (Reed, Clin Oncol 2007;19:588-590).
    Adamson DJ; Qureshi S; Harbour R; Twaddle S; Kelnar C; Lowe GD
    Clin Oncol (R Coll Radiol); 2007 Oct; 19(8):628. PubMed ID: 17714926
    [No Abstract]   [Full Text] [Related]  

  • 2. Scottish Intercollegiate Guidelines Network (SIGN) 84 -- National Clinical Guideline for the Management of Breast Cancer in Women.
    Reed MW
    Clin Oncol (R Coll Radiol); 2007 Oct; 19(8):588-90. PubMed ID: 17643275
    [No Abstract]   [Full Text] [Related]  

  • 3. Scottish Intercollegiate Guidelines Network: the first 15 years (1993-2008).
    Harbour R; Lowe G; Twaddle S
    J R Coll Physicians Edinb; 2011 Jun; 41(2):163-8. PubMed ID: 21677923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does pharma fund the pipers? - Scottish Intercollegiate Guidelines Network (SIGN) guidelines 90 - diagnosis and management of head and neck cancer, October 2006.
    Wilson JA
    Clin Oncol (R Coll Radiol); 2008 Nov; 20(9):661-3. PubMed ID: 18450433
    [No Abstract]   [Full Text] [Related]  

  • 5. [Is there progress in chemotherapy for breast cancer?].
    Wenzel C; Schmidinger M; Huber H
    Wien Klin Wochenschr; 2001 Apr; 113(9):306-20. PubMed ID: 11388076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of obesity in Scotland: development of the latest evidence-based recommendations.
    Thompson J
    Proc Nutr Soc; 2010 May; 69(2):195-8. PubMed ID: 20202278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence-based child health: SIGN and NICE.
    Kelnar CJ
    Arch Dis Child Educ Pract Ed; 2008 Dec; 93(6):190-8. PubMed ID: 19028929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trastuzumab beyond progression in advanced breast cancer: national guidance versus oncologist's decision.
    Wong HH; Collins J; McAdam K; Wilson C
    Oncology; 2014; 86(1):22-3. PubMed ID: 24335099
    [No Abstract]   [Full Text] [Related]  

  • 9. Implementation of a national guideline on prophylaxis of venous thromboembolism: a survey of acute services in Scotland. Thromboembolism Prevention Evaluation Study Group.
    Walker A; Campbell S; Grimshaw J
    Health Bull (Edinb); 1999 Mar; 57(2):141-7. PubMed ID: 12828138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Scottish Intercollegiate Guidelines Network (SIGN) guideline for head and neck cancer: pointing in the right direction?
    Newman H; Albooz H
    Clin Oncol (R Coll Radiol); 2008 Nov; 20(9):664-5. PubMed ID: 18835025
    [No Abstract]   [Full Text] [Related]  

  • 11. Scottish Intercollegiate Guidelines Network (SIGN) guidelines on tonsillectomy: a three cycle audit of clinical record keeping and adherence to national guidelines.
    Williams A; Lee P; Kerr A
    J Laryngol Otol; 2002 Jun; 116(6):453-4. PubMed ID: 12385359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuation of trastuzumab beyond disease progression.
    Montemurro F; Faggiuolo R; Redana S; Donadio M; Minischetti M; Durando A; Vietti-Ramus G; Buosi R; Aglietta M
    J Clin Oncol; 2005 Apr; 23(12):2866-8; discussion 2868-9. PubMed ID: 15838006
    [No Abstract]   [Full Text] [Related]  

  • 13. When the evidence is weak, caution should be applied.
    Lancet Oncol; 2010 Sep; 11(9):805. PubMed ID: 20816369
    [No Abstract]   [Full Text] [Related]  

  • 14. Review of testing and use of adjuvant trastuzumab across a cancer network--are we treating the right patients?
    Coulson SG; Kumar VS; Manifold IM; Hatton MQ; Ramakrishnan S; Dunn KS; Purohit OP; Bridgewater C; Coleman RE
    Clin Oncol (R Coll Radiol); 2010 May; 22(4):289-93. PubMed ID: 20347281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation by Scottish otolaryngologists of the Scottish Intercollegiate Guidelines Network document Management of Sore Throats and the Indications for Tonsillectomy: four years on.
    Clement WA; Dempster JH
    J Laryngol Otol; 2004 May; 118(5):357-61. PubMed ID: 15165310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of trastuzumab in the management of HER2-positive metastatic breast cancer: an updated review.
    Tokuda Y; Suzuki Y; Saito Y; Umemura S
    Breast Cancer; 2009; 16(4):295-300. PubMed ID: 19609647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison between clinical decisions made about lung cancer patients and those inherent in the corresponding Scottish Intercollegiate Guidelines Network (SIGN) guideline.
    Sleeman D; Moss L; Gyftodimos E; Nicolson M; Devereux G
    Health Informatics J; 2010 Dec; 16(4):260-73. PubMed ID: 21216806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scottish Intercollegiate Guidelines Network (SIGN) 87--the management of oesophageal and gastric cancer.
    Crosby T
    Clin Oncol (R Coll Radiol); 2008 Sep; 20(7):528-9. PubMed ID: 18538555
    [No Abstract]   [Full Text] [Related]  

  • 19. Unusual problems in breast cancer and a rare lung cancer case. Case 1. Clinical complete response of breast cancer metastases after trastuzumab-based immunotherapy.
    Tonini G; Vincenzi B; Santini D; Avvisati G; La Cesa A; Baldi A
    J Clin Oncol; 2003 Jun; 21(11):2215-6. PubMed ID: 12775749
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical practice guidelines for breast cancer rehabilitation: syntheses of guideline recommendations and qualitative appraisals.
    Harris SR; Schmitz KH; Campbell KL; McNeely ML
    Cancer; 2012 Apr; 118(8 Suppl):2312-24. PubMed ID: 22488705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.